The use of choline-PET/CT (C-PET/CT) in prostate radiotherapy planning has been evaluated in two principal settings: patient selection for treatment and target volume delineation. Choline-based tracers are used, as the relatively low glucose metabolism of prostate cancer means FDG-based tracers perform poorly .
KeywordsProstate Cancer Insufficient Evidence Localise Prostate Cancer Stereotactic Radiotherapy Bone Involvement
- 2.Picchio M, Briganti A, Fanti S, Heidenreich A, Krause BJ, Messa C, et al. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol. 2011;59(1):51–60.CrossRefPubMedGoogle Scholar
- 3.Evangelista L, Guttilla A, Zattoni F, Muzzio PC. Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis. Eur Urol. 2013;63(6):1040–8.CrossRefPubMedGoogle Scholar
- 9.Fonteyne V, Villeirs G, Speleers B, De Neve W, De Wagter C, Lumen N, et al. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion. Int J Radiat Oncol Biol Phys. 2008;72(3):799–807.CrossRefPubMedGoogle Scholar